MassMutual Private Wealth & Trust’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.33K Hold
159
﹤0.01% 1959
2026
Q1
$2.31K Sell
159
-1
-0.6% -$12 ﹤0.01% 1940
2025
Q4
$1.54K Buy
160
+69
+76% +$661 ﹤0.01% 2061
2025
Q3
$855 Buy
91
+55
+153% +$525 ﹤0.01% 2163
2025
Q2
$381 Buy
36
+23
+177% +$290 ﹤0.01% 2253
2025
Q1
$195 Hold
13
﹤0.01% 2300
2024
Q4
$214 Buy
+13
New +$256 ﹤0.01% 2247
2023
Q3
Sell
-64
Closed -$1.66K 1968
2023
Q2
$1.66K Hold
64
﹤0.01% 1522
2023
Q1
$1.84K Sell
64
-3,871
-98% -$115K ﹤0.01% 1443
2022
Q4
$116K Hold
3,935
﹤0.01% 393
2022
Q3
$94K Buy
3,935
+74
+2% +$1.7K ﹤0.01% 394
2022
Q2
$86K Sell
3,861
-88
-2% -$1.96K ﹤0.01% 403
2022
Q1
$99K Buy
3,949
+88
+2% +$2.68K ﹤0.01% 392
2021
Q4
$138K Hold
3,861
0.01% 370
2021
Q3
$164K Hold
3,861
0.01% 345
2021
Q2
$167K Hold
3,861
0.01% 349
2021
Q1
$157K Hold
3,861
0.01% 351
2020
Q4
$175K Hold
3,861
0.01% 354
2020
Q3
$137K Hold
3,861
0.01% 354
2020
Q2
$146K Hold
3,861
0.01% 341
2020
Q1
$112K Hold
3,861
0.01% 332
2019
Q4
$200K Buy
3,861
+1,594
+70% +$92.6K 0.01% 348
2019
Q3
$124K Hold
2,267
0.01% 367
2019
Q2
$92K Hold
2,267
0.01% 384
2019
Q1
$68.6K Hold
2,267
﹤0.01% 400
2018
Q4
$76.2K Buy
+2,267
New +$81.8K 0.01% 384
2018
Q3
Sell
-14
Closed -$448 974
2018
Q2
$448 Buy
+14
New +$577 ﹤0.01% 1064

Other funds holding ANIK

MassMutual Private Wealth & Trust's ANIK Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Anika Therapeutics (ANIK) position steady in Q2 2026 at 159 shares worth $2.33K. The position accounts for ﹤0.01% of the portfolio, ranked #1959.

MassMutual Private Wealth & Trust first reported a position in ANIK in Q2 2018 and has held it in 27 quarters since. The position peaked at $200K in Q4 2019. 10 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • MassMutual Private Wealth & Trust held 159 shares of Anika Therapeutics worth $2.33K as of Q2 2026.
  • MassMutual Private Wealth & Trust left its Anika Therapeutics share count unchanged in Q2 2026.
  • Anika Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1959 holding.
  • MassMutual Private Wealth & Trust first reported a position in Anika Therapeutics in Q2 2018 and has held it in 27 quarters since.
  • MassMutual Private Wealth & Trust's Anika Therapeutics position peaked at $200K in Q4 2019.
  • 10 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.